A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-κB activation

Chinese Medical Journal

Volumn 120, Issue 20, 2007, Pages 1830-1835

  Zhang, Bin ^a   Guan, Cheng Chao ^a   Chen, Wan Tao ^b   Zhang, Ping ^b   Yan, Ming ^b   Shi, Jiu Hui ^a   Qin, Chua Lin ^c   Yang, Qian ^d  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c BAYLOR COLLEGE OF DENTISTRY   (United States)

^d HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

A20; Invasion; Nuclear factor B; Salivary adenoid cystic carcinoma

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLASMID VECTOR; TUMOR NECROSIS FACTOR ALPHA;

ADENOID CYSTIC CARCINOMA; ARTICLE; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND CANCER; WESTERN BLOTTING;

EID: 36148961963     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200710020-00020     Document Type: Article

References (32)

1. Khan AJ. DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, et al. Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer 2001; 96: 149-158.
2. Whatley WS, Thompson JW, Rao B, Salivary gland tumors in survivors of childhood cancer. Otolaryngol Head Neck Surg 2006; 134: 385-393.
3. Codd JD, Salisbury JR, Packham G, Nicholson LJ. A20 RNA expression is associated with undifferentiated nasophryngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol 1999; 187: 549-555.
4. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 2000; 289: 2350-2354.
5. Beyaert R, Heyninck K, Van Huffel S. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. Biochem Pharmacol 2000; 60:1143-1151.
6. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109 Suppl: S81-96.
7. Aggarwal BB. Nuclear factor-kappaB: the enemy within. Cancer Cell 2004; 6: 203-211.
8. Helbig G; Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, et al. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 2003; 278: 21631-21638.
9. McNulty SE, Tohidian NB, Meyskens FL, Jr. RelA, p50 and inhibitor of kappa B alpha are elevated in human metastatic melanoma cells and respond aberrantly to ultraviolet light B. Pigment Cell Res 2001; 14: 456-465.
10. Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, et al. Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res 2001; 7: 4136-4142.
11. Shishodia S, Aggarwal BB. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer. Cancer Treat Res 2004; 119: 139-173.
12. Zhang JL, Peng B, Chen XM. The relation of nuclear factor kappa B to angiogenesis and clinical outcomes in adenoid cystic carcinoma of salivary glands. Chin J Stomatol (Chin) 2005; 40:495-499.
13. Zhang J, Peng B, Chen X. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res 2005; 11: 7334-7343.
14. Fukuda M, Fukuda F, Horiuchi Y, Oku Y, Suzuki S, Kusama Y, et al. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors. In Vivo 2006; 20: 467-472.
15. Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424-12427.
16. Jaattela M, Mouritzen H, Elling F, Bastholm L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J Immunol 1996; 156: 1166-1173.
17. De Valck D, Jin DY, Heyninck K, Van de Craen M, Contreras R, Fiers W, et al. The zinc finger protein A20 interacts with a novel anti-apoptotic protein which is cleaved by specific caspases. Oncogene 1999; 18: 4182-4190.
18. Zhang SQ, Kovalenko A, Cantarella, G, Wallach D. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. Immunity 2000; 12: 301-311.
19. De Valck D, Heyninck K, Van Criekinge W, Vandenabeele P, Fiers W, Beyaert R. A20 inhibits NF-kappaB activation independently of binding to 14-3-3 proteins. Biochem Biophys Res Commun 1997; 238: 590-594.
20. Heyninck K, Beyaert R. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 1999; 442: 147-150.
21. Heyninck K, Beyaert R. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 2005; 30:1-4.
22. Evans PC, Ovaa H, Hamon M, Kilshaw PJ, Hamm S, Bauer S, et al. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem J 2004; 378: 727-734.
23. Evans PC, Smith TS, Lai MJ, Williams MG, Burke DF, Heyninck K, et al. A novel type of deubiquitinating enzyme. J Biol Chem 2003; 278: 23180-23186.
24. Krikos A, Laherty CD, Dixit VM. Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by kappa B elements. J Biol Chem 1992; 267: 17971-17976.
25. Rothwarf DM, Zandi E, Natoli G, Karin M. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature 1998; 395: 297-300.
26. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93: 1231-1240.
27. Lee SY, Lee SY, Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J Exp Med 1997; 185: 1275-1285.
28. Rothe M, Xiong J, Shu HB, Williamson K, Goddard A, Goeddel DV. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci USA 1996; 93: 8241-8246.
29. Hah N, Lee ST. An absolute role of the PKC-dependent NF-kappaB activation 7 for induction of MMP-9 in hepatocellular carcinoma cells. Biochem Biophys Res Commun 2003; 305: 428-431.
30. Bancroft CC, Chen Z, Dong G, Sunwoo JB, Yeh N, Park C, et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 2001; 7: 435-442.
31. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, Vander Jagt DL, Abcouwer SF. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCI8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 2004; 64; 4858-4869.
32. Olivier S, Robe P, Bours V. Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochem Pharmacol 2006; 72: 1054-1068.